David C. Marek - 19 Jan 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Principal Executive Officer, Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Jan 2022
Net transactions value
-$291,868
Form type
4
Filing time
21 Jan 2022, 15:08:04 UTC
Next filing
19 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $291,868 -19,882 -5.6% $14.68 337,983 19 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.